Latest revenue
$3.2M
as of 2026-03-31
Latest net income
—
as of 2026-03-31
Net margin
—
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $7.8M
- Enterprise value
- $7.8M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $2.52
- 52-wk low
- $0.15
- Beta
- —
- Shares out
- 48.6M
5-year trend
What this company does
Item 1. Business Overview Through our wholly-owned subsidiary VSee Lab, we offer a comprehensive telehealth platform for U.S. hospitals and enterprises. Through VSee Lab, we offer a set of telehealth software building blocks, data connectors, and workflow templates that can be rapidly configured into the client’s workflows. Our offerings allow clinicians without programming experience to configure our building blocks into their existing workflow without requiring programmers — i.e. — no code. In addition, our building blocks allow programmers to increase their productivity with simple coding to piece together our building blocks — i.e. — low code. At the core of our platform is a…
AI summary unavailable — showing raw filing excerpt
Generated from VSEE's filing dated 2026-03-31
Key risks
Item 1A. Risk Factors Risks Related to Our Operation of Business In connection with the preparation of our financial statements for the fiscal year ended December 31, 2024, we identified material weaknesses in our internal control over financial reporting and clinical trial expenses. If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our Common Stock and listed Warrants. If the interpretations, estimates or judgments we use to…
AI summary unavailable — showing raw filing excerpt
Generated from VSEE's filing dated 2026-03-31
Profitability
Gross margin
50.3%
26.9%Operating margin
-65.6%
89.0%Net margin
-553.7%
623.3%Return on equity
36.0%
63.0%Return on assets
-288.6%
10.4%Leverage
Debt / equity
-1.11×
66.2%Debt / assets
995.0%
592.5%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $3.2M | -4.9% | — | — | — |
Q4 2025 2025-12-31 | $3.9M | — | — | — | — |
Q3 2025 2025-09-30 | $4.0M | +18.7% | — | — | — |
Q2 2025 2025-06-30 | $3.4M | +98.1% | $-2.6M | -691.9% | -77.1% |
Q1 2025 2025-03-31 | $3.3M | — | — | — | — |
Q4 2024 2024-12-31 | — | — | $-4.7M | — | — |
Q3 2024 2024-09-30 | $3.4M | +131.1% | $-51.8M | -66204.9% | -1542.8% |
Q2 2024 2024-06-30 | $1.7M | +32.7% | $-330.0K | -225.2% | -19.3% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Health Services · SIC 8000
Your notes
Keep private notes on VSEE — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns VSEE
Institutional value
$66.3K
Total shares held
385.1K
Distinct holders
6
-10 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 213.7K | $53.4K | — | New |
| 2 | UBS Group AG | 35.2K | $8.8K | +7.9K (+28.8%) | Added |
| 3 | Wealthcare Advisory Partners LLC | 14.1K | $3.5K | +0 (+0.0%) | No change |
| 4 | VANGUARD FIDUCIARY TRUST CO | 2.2K | $543 | — | New |
| 5 | Cygnus Capital Advisors, LLC | 120.0K | $30 | — | New |
| 6 | SBI Securities Co., Ltd. | 1 | $0 | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once VSEE's latest filing finishes processing.